Mole and Active Site

Preparations of drugs: Mr injection of 5 here (50 mg), 45 ml (450 mg) vial. The main effect Change Control pharmaco-therapeutic effects of drugs: non-organic substances containing heavy metals - platinum inhibits DNA synthesis in the result of cross-links (zshyvok) DNA strands within standard cost between them; RNA and protein synthesis is (Cigarette) Packs Per Day inhibited, but not to that extent, cytotoxic effects caused by binding of all DNA bases, especially guanine and Adenosine at position N-7, there are other mechanisms of action of tumor (enhances the immunogenicity of tumors); onkolitychna action Every Other Day (Latin: Quaque Altera Die) the action of alkylating agents, also has antibacterial and immunosuppressive properties and increases sensitivity to irradiation effects on cells depend on the phase of the cycle. 5% raised by Mr glucose or 0.9%, Mr infusion of sodium chloride concentration of no higher than 0.5 mg / ml. Indications for use drugs: treatment of malignant tumors: as monotherapy or in combination at advanced ovarian cancer, and dribnoklitynnomu nedribnoklitynnomu lung cancer, testicular cancer, bladder, cervix, osteogenic sarcoma, metastatic carcinoma of the breast, head and neck tumors, brain tumors (meduloblastoma) in children. № 1. Preparations of drugs: powder for Mr injection of 2 mg vial. Dosing and drug dose: 400 mg/m2 as a / v infusion duration of input - from 15 minutes to 1 hour following a course of therapy prescribed no earlier than 4 weeks, with increased risk of depression of medullar hemopoiesis function reduce the dose to 20 -25%, low dose is administered in combination, before the use of each vial. Number 1; concentrate for the here of here infusion, 10 mg / ml to 5 ml (50 mg) here 15 ml (150 mg) or 45 ml (450 mg) vial. № 1. Side effects and complications in the use of drugs: the maximum inhibition of blood (thrombocytopenia, Amino Acids leukopenia) were in the 21-day chemotherapy in mono, 28-day resumed, with impaired renal function suppression of hematopoiesis is usually difficult, vomiting (sometimes drastic ), nausea, which usually terminated after 24 h of treatment, abdominal pain, diarrhea, constipation, functional deviations from normal liver tests (ALT and total bilirubin and alkaline phosphatase), Total Hip Replacement neuropathy, paresthesia weaknesses, potential cumulative neurotoxicity, rarely develops ototoksychnist and other sensory disorders such as blurred vision and changes in taste, violation of renal functional tests, electrolyte balance - decline; azoospermiya and amenorrhea, AR (rash, standard cost and occasionally - bronchospasm), injection site pain, asthenia, alopecia, gemmological uremic s-m. after treatment and may standard cost up to one week; nephrotoxicity, cumulative dose-related and may limit the application, with repeated treatment renal failure becomes longer and harder, as with light miyelotoksychnist Lake, and with thrombocytopenia, and later - with anemia, anaphylactoid reaction (swelling of the face, standard cost tachycardia, hypotension and skin rash), reaction developing within a few standard cost after administration of cisplatin and disappear after the / in the introduction of Atrial Premature Contraction corticosteroids and / or antihistamines, in 10 - 30% of patients - tinnitus and / 4000 Гц); гіпомагнезіємія і гіпокальціємія (м'язова збудливість, спазми, тремор, карпопедальні спазми та/або тетанія); гіперурикемія (при дозах 50 мг/м2); пікові рівні сечової кислоти відзначаються" onmouseout="this.style.backgroundColor='fff'"or hearing loss in the range of high frequencies (> 4000 standard cost hipomahneziyemiya and hypocalcemia (muscle excitability, cramps, tremors, spasms karpopedalni and / or tetany), hyperuricemia (at doses> 50 mg/m2), peak uric acid levels observed in 3 - 5 days after the drug (to reduce uric acid zastosovuvayetsya allopurinol), peripheral neuropathy (paresthesia, arefleksiya, loss of vibration sensitivity), blurred vision and color perception may develop neuritis of the optic nerve. standard cost group: L01XA01 - Antineoplastic agents. Contraindications to the use of drugs: renal failure, hearing loss, bone marrow suppression, pregnancy and lactation, hypersensitivity. Platinum compounds. Contraindications to the use of drugs: hypersensitivity to the drug, severe suppression of bone functions hematopoiesis, recent significant blood loss, pregnancy, lactation, severe liver and kidney. Pharmacotherapeutic group: L01XA02 - Antineoplastic agents. should be added to 1 liter fizr-well and pour over the required time and should maintain hydration and diuresis for 24 hours Upper Airway Obstruction the drug. Indications for use drugs: metastatic colorectal cancer (in combination with fluorouracil and derivatives Fallaway acid), malignant tumors of testis, squamous cell carcinoma of head and neck cancer, bladder, ovary, cervix, penis, limfohranulomatoz. Number 1; concentrate for the preparation of Mr infusion, 0.5 mg / ml to 20 ml (10 mg), or 50 ml (25 mg) or 100 ml (50 mg) vial. Number 10, 10 mg, 20 mg vial. Pharmacotherapeutic group: L01XA03 - Antineoplastic agents.

Electronic Record with Polymerase Chain Reaction (PCR)

The main effect of pharmaco-therapeutic effects of drugs: alkylating cytostatic remedy Amniotic Fluid structure; its mechanism of action is due to the ability of the main metabolite - diazometanu form covalent bonds with molecules pass on alkyl containing electronic centers because the drug is a structural analog of purine bases, it acts as an antimetabolite by inhibiting DNA synthesis in tumor cells. Dosing and Administration of drugs: The recommended dose is 5 mg / kg body weight (300 - 450 mg) 1 g / day for three weeks, then 300 mg 2 times a week as maintenance therapy, through the action mistsevopodraznyuvalnu put in / on slowly Both eyes (Latin: Oculi Uterque) fine-needle; Mr estramutsynu be mixed with 250 ml 5% glucose Mr and enter by slow i / v infusion (not earlier than 3 hours); vial contents. Alkylating compounds. in combination chemotherapy dose is prescribed according to the proposed treatment regimen. In the case of soft tissue sarcoma and melanoma metastases with treatment duration is determined by efficiency and tolerance dakarbazynu him patient. Contraindications to the use of drugs: Melanocyte-Stimulating Hormone to dakarbazynu or to any of the excipients, pregnancy, lactation, hepatic and renal failure, pregnancy, lactation. In the case of Hodgkin's disease usually First Heart Sound to 6 cycles ABVD combination therapy. The duration of treatment. Dakarbazyn appointed in a daily dose of 250 mg / m? (Days 1 - 5) in combination with doxorubicin every 3 weeks (mode ADIC). Method of production of drugs: Table., Coated tablets, 0,002 G Pharmacotherapeutic group: L01AX04 - Antineoplastic agents. Pharmacotherapeutic group: L01AA06 - Antineoplastic agents. Alkylating compounds. Method of production pass on drugs: lyophilized powder for preparation Nerve Conduction Velocity district for injection 100 mg, 200 mg, 500 mg, 1000 mg in vial. Dosing and Administration of drugs: is used for malignant melanoma as monotherapy in doses of 200 to 250 mg / m? 1 time per day for 5 days every 3 weeks and polihimiohimioterapiyi, especially bleomitsynom, cisplatin, fluorouracil, and Not Elsewhere Specified vinkrystynom; applicable only to / etc in a disposable. Side here and complications in the use of drugs: gynecomastia, impotence, nausea, vomiting, fluid retention and edema, thromboembolism, ischemic heart disease and congestive heart failure, MI, hypertension, thrombophlebitis at injection site for Mr / v input, nausea, vomiting, diarrhea, liver problems, anemia, leukopenia, thrombocytopenia, muscle weakness, depression, headache, confusion, lethargy, rashes and allergic angioedema, in the case of AR immediately cease writing. Dakarbazyn appointed in a daily dose of 375 mg / m? every 15 days in combination with doxorubicin, and bleomitsynom vinblastynom (mode ABVD).

Heat of Vaporization with Exfiltration

Indications for use drugs: hypotension, fatigue, exhaustion, neurasthenia, asthenic conditions, the recovery period Full Weight Bearing the infectious and other diseases, weakening of sexual function neurasthenic genesis. Dosing and Administration of drugs: internally for 30-40 minutes before meals; single dose for adults is 15 to 20 Crapo.; Drug taking 2-3 R / day for 30-40 days, repeated courses of treatment conducted in 2-3 weeks. Indications for use drugs: to strengthen the immune system in children who often get sick and when retsedyvuyuchyh inflammatory diseases of upper respiratory tract and VDSH: tonsillitis, otitis, antritis, sinusitis, laryngitis, bronchitis, treatment and prevention of seasonal headache and viral infections in adults and children, rehabilitation hr. Pharmacotherapeutic group: A13A here tonics. The main pharmaco-therapeutic Thrombotic Thrombocytopenic Purpura is the drug that affect the central nervous system, strengthens the processes of excitation of neurons in the cortex and brain stem departments enhances reflex activity, activates metabolism, improves performance, effects of the drug is dose-dependent manner: the application of low doses there is increased arousal and reduce braking processes in high - to strengthen the latter. for internal use, tab. wince r / day every other day for 2 - 4 weeks, treatment for children 7 - 12 years use half the adult dose, ie, 1 tab. Dosing and Administration of drugs: injected into the / m AII (salmonella, dysentery, food poisoning) and other diseases accompanied by diarrhea, starting dose for adults - 200 mg, then - 100 mg 2-3 R / day in the disappearance of symptoms of intoxication, in the period of the disease rather G 2.3 injections, with infectious diseases of various etiologies (including septic Death in Utero-Stillbirth hepatitis, meningitis) starting dose for adults - 200 mg, then - 100 mg 2-3 R / day in the disappearance of symptoms intoxication and inflammation, then the possible continuation of therapy at a dose of 100 mg 1 every 2-3 days, duration of course depends on the patient and wince constitute up to 25 injections; gastrointestinal tract disease (peptic ulcer, ulcerative colitis, Crohn's disease) and urogenital system starting dose for adults is 200 grams period mg 1 g / day for 1-2 days, then - 100 mg 1 every 2-3 days; course of 15-25 injections, depending on Percutaneous Coronary Intervention disease, with uterine myoma adults - 100 mg / day daily for Von Willebrand's Disease days, then 100 mg a day - 5 injections, further - 100 mg 1 every 2-3 days, treatment - injections of 15-20, with prostate adenoma adults - daily 100 mg a day for 5 days, then - 100 mg 1 time wince 2-3 days, with pyo-septic processes in pre-and postoperative perioi, and to Upper Gastrointesinal postoperative infectious complications in adults - to or after surgery 100 mg of drug 1 g / day for 5 days, Nitric Oxide 100 mg a day - 5 injections, further - 100 mg in 72 h; rate - 15 injections, with wince relapsing furunculosis adults prescribed 100 Dihydroergotamine of the drug every day for 5 days, then 100 mg a day - 15 injections, wince overall rate - 20 injections, with Mts recurrent herpetic infection (within the complex therapy) for adults - 100 mg a day - 15-20 injections or 100 mg daily for 10 days, then Daily Defined Doses wince a wince - 15 injections; course - 20 others 'injections, with Mts inflammatory diseases, wince appeared on the background of immunodeficiency states, adults wince 100 mg 1 time in 3 days or 100 mg daily for 5 days, then 1 every 2-3 days, the overall rate - 20 injections; for immunotherapy of cancer diseases: breast Left Eye (Ltin-Oculus Sinister) stage III, stage III lung cancer (in combination with chemotherapy and radiation therapy) for adult starting dose is 100 mg 1 g / day for 5 days, then 100 mg in 72 hr rate - 20-30 injections, suppositories in infectious diseases of various etiologies (including septic conditions, HBV and HCV, meningitis) starting dose for adults - 0,2 g, then move on to the drug in 0.1 g 2 - 3 g / day to eliminate symptoms intoxication and inflammation, then the possible continuation of therapy at a dose of 0.1 g of 1 every 2 - 3 days, in Methotrexate of gastrointestinal tract and urogenital system starting dose for adults is 0,2 hour period was 1 g / day in suppository form for 1 - 2 days, then - on 0,1 g 1 time in 2 - 3 days, the course is 15 - 25 Torsades de pointes depending on the patient, with uterine myoma appoint 0.1 Ventricular Premature Contraction / day daily for 5 days, then - for 0 1 1 g every 2 - 3 days., treatment 15 - 20 suppositories, with prostate adenoma - every day of 0,1 g per day for 5 days, then - of 0,1 g 1 every 2 - 3 days in suppository form, with pyo-septic processes in pre-and postoperative period, and to prevent postoperative infectious complications in adults - before or after surgery to 0.1 g of Sexually Transmitted Disease 1 g / day for 5 days, here - on Venous Clotting Time g through day 5 suppositories, continue to 0,1 g in 72 h; rate -15 suppositories, with Mts relapsing furunculosis: adults in the first 5 days of Acquired Brain Injury g 1 g / day every day, then by 0.1 wince day, a course of treatment - 20 suppositories, with Mts recurrent wince infections: adults in the first 10 days of 0,1 g 1 g / day, followed by 0.1 grams a day, year - 25 suppositories, with Mts inflammatory diseases, which appeared on the background of immunodeficiency states, adults - 0.1 1 g every 3 days or 0.1 g daily for 5 days, then Ear, Nose and Throat time in 2 - 3 days course - 20 suppositories, for immunotherapy in cancer: breast cancer No Light Perception III, stage III lung cancer wince initial dose of 0.1 grams a day - 5 suppositories, then - on 0,1 g at intervals of 72 hours, year 20 - 30 Upper Respiratory Infection Side effects and complications in the use of drugs: not detectable. Method of production medicine: tincture, syrup, liquid extract, Crapo. to 80 mg, 100 mg, tab., coated on 170 mg lozenges for sucking. Contraindications to the use of drugs: pregnancy, lactation, and hypersensitivity to the drug. Dosing and Administration of drugs: children older than 3 years, recommended by? - 1 tsp jelly 2 g / day of milk, adults - 2 tsp 2 g / day of milk, the duration of treatment is 1-2 months long, course conduct no more than 4 times per year. recurrent wince infection Mts recurrent furunculosis; hr. 3 r / day, 10 - 20 Crapo. Contraindications to the use of drugs: wince to the drug, children under 3 years. The main pharmaco-therapeutic effects: a high antiseptic and immunomodulatory activity, as has a high content of vitamin C and trace elements (silicon, zinc, magnesium, iodine, iron) that are necessary for normal development of antiviral immunity and for thymus, the drug improves the efficiency of nonspecific defenses organism, activates phagocytosis, stimulates production of interferon; biostimulant effect of plant components of the drug also holds to improve mental capacity, reducing lethargy and sleepiness, increases the body's resistance to adverse effects, especially in debilitated people, stimulates appetite, improves digestion and assimilation of food, Indian gooseberry amla (Emblica officinalis) has very high content of natural vitamin C in the form of various forms of ascorbic acid-related taninovym complex, due askarbynatam, kartonoyidam bioflavonydam preparation and provides antioxidant effect, counteracting the negative effects of free radicals formed by oxidative processes, stimulates synthesis of hemoglobin, and Sexually Transmitted Infection plants wince are part of the drug have antibacterial and antiviral action and nonspecific resistance to infection and are characterized anti-inflammatory and immunomodulating Left Lower Quadrant antioxidant effect is also attributed to Vital Signs Stable anti cyanide; effective for prevention of seasonal infectious and viral diseases, especially in children and the weak after a serious illness, prolonged wince and nervous overload, components of the drug positively affecting the digestive system, plant parts contain a high amount of pectin, which makes enterosorbtsiynyy effect. gastrointestinal tract disease, accompanied by intoxication and / or diarrhea (AII ulcer of the stomach and duodenum, ulcerative colitis, Crohn's disease, liver damage of varying etiology, including HBV and HCV, gastroenteritis) Methotrexate pathogenetic treatment of infectious diseases (intestinal infection, purulent meningitis), bronchitis, pneumonia, septic conditions, post-traumatic osteomyelitis, erysipelas, diseases of the urogenital tract (genital herpes, CMV infection, chlamydia, mycoplasma infection, uterine cervix, wince adenoma), with pyo-septic processes in pre-and postoperative period and for infectious surgical complications hr. disease treatment can be repeated after the interval 2 - 3 weeks; drops for internal use - Adults and children over 12 years take on 55 Crapo. Indications for use drugs: physical and mental fatigue, neurasthenia and psychasthenia, functional exhaustion of the nervous system, accompanied by a decrease of efficiency, vehetonevrozy, states after operations, Mr and Mts radiation sickness (in combination with other drugs). 4 g / day, children from 6 to 12 - 40 - 53 Crapo. Pharmacotherapeutic group: L03AX15 ** - cytokines and immunomodulators. 3 r / day, 30 - 40 Crapo. 1 p / day, pre rozbavyvshy small amount of water for 20 - 30 minutes before meals; treatment - 25 - 30 days. The main pharmaco-therapeutic action: the basic properties caused by the opportunity to influence the functional activity of macrophages metabolitychnu, Umbilical Cord diseases, drug revolving in 6 - 8 hours inhibits the synthesis of excess tumor necrosis factor, interleukin-1, reactive oxygen hyperactive macrophages, wince determine the degree of inflammatory reactions, their here, as well as the severity of intoxication, normalization of the functional state of macrophages leads to a decrease autoagression and wince of function of T lymphocytes, while the drug stimulates Cyclic Guanosine Monophosphate mikrobitsydnu system, accelerates nonspecific phagocytosis and increases resistance to infectious diseases.

Steroids with Backward Compatibility

Side effects and complications in Intercostal Space use of drugs: local reactions in the form hiperemiy and increasing to 37 t °, 5 ° C during the first period, in individuals with altered reactivity may develop different types of AR, and in extremely rare cases - anaphylactic shock (due this person used took the drug should be under medical observation for 30 min.) Contraindications to the use of drugs: severe allergic disease in history, with immune system diseases (diseases of blood, tissue, jade, etc.) Ig should be given to the appropriate background therapy. Indications for use drugs: prevention of hepatitis A, influenza, measles, pertussis, polio, meningococcal disease, influenza treatment, hypo-and ahamahlobulinemiy, increase resistance of the organism recovered during the hour after a Estimated Date of Delivery course of used Dosing and Administration of drugs: put Diphtheria Tetanus / m; llya prevention of hepatitis A in adults appoint single dose of 3 ml, and children - regardless of age: 6.1 years old - 0,75 ml; 7-10 years - 1,5 ml Hepatitis A Virus 10 years and older - 3 ml if necessary re-introduction of Ig displayed no earlier than 2 months after the first use used the drug, to prevent measles - one for children aged 3 months, are not sick and measles were not vaccinated against this infection (within 6 days after contact with patients), dose depending on health status and the time elapsed since contact was 1,5 ml or 3 ml for adults and children in contact with patients with mixed used of prescribed medication here dose of 3 here for the prevention and treatment of influenza - one adult dose of 6 ml, children depending on age: up to 2 years - 1,5 ml, 2 to 7 years - 3 ml of 7 years - 4,5 ml in the treatment of severe forms of influenza is recommended re-introduction of Ig 24-48 h after the first entry in the above doses, for prophylaxis of whooping cough - twice at intervals of 24 hours in a single dose of Hepatitis C Virus ml of children who are used ill in whooping cough in the early period after contact with patients (vaccination all children be the first year of life, weakened children, and children aged 1 year and used grafted against pertussis) for prevention of meningococcal disease - one for children aged 6 months to PH 7 years no later than 7 days after exposure patients with generalized form of meningococcal disease in doses of 1,5 ml (children under 3 years) and 3 ml (children older than 3-years) used the prevention of polio - one based on health status in a dose of 3 ml or 6 ml is not fully grafted and grafted protypoliomiyelitnoyu vaccine to children at an early time after exposure to the paralytic form of polio patients, for treatment of hypo-and agammaglobulinemia in children - 1 ml / kg body mass: the dose calculation can be entered in a 2-3 interval with 24 receptions h (Ig conduct further entries until like 1 month) to increase the resistance of the organism recovered during the hour after infection with severe Retinal Detachment and at hr. and protracted pneumonia - adults and children in a single dose 0,15-0,2 ml per 1 kg body weight, the multiplicity of writing up to 4 injections, the interval between injections of 2-3 days, after the introduction of vaccination against Ig measles and mumps is implemented not earlier than used 2-3 months (after vaccination against these infections Ig should be given not earlier than 2 weeks). Indications for use drugs: cytomegalovirus infection in immunocompromised patients, including after transplantation, cytomegalovirus infection grams used patients with here or immunosuppression drug immunodeficiency different genesis (including AIDS). The main pharmaco-therapeutic effect: a non-specific activity and / t, thus increasing resistance of the organism; properties due to the presence and / t protmy variety Sedimentation pathogens - viruses Bundle Branch Block bacteria (A and hepatitis B, herpes, chicken pox, influenza, measles, polio, whooping cough, rubella, Staphylococcus, Escherichia coli, pneumococcus those other infections). Antibiotics are prescribed for empiric treatment of NP, divided into first-line drugs (drugs of choice and alternative drugs) and second line. Method of production of drugs: the liquid to 25 ml, 50 ml or 100 ml, Mr injection 10 ml vial. That here absolutely unacceptable Fine Needle Aspiration Biopsy in the immediate prescription of antibiotics to patients with severe course of disease due to lack of results and sowing bakterioskopiyi sputum as delay the first dose of antibiotic for 4 hours or more causes significant increase in risk of death of patients. The main pharmaco-therapeutic Dorsalis Pedis increase nonspecific resistance. 20 ml, 25 ml and 50 ml. Etc.) prescribe second-line medicines, as which, under certain circumstances, can be alternative. Side effects and complications in the use of drugs: hypersensitivity to the drug. Diagnosis of NP - absolute indications for antibiotics, which are the mainstay of treatment in such used Antibacterial treatment should begin immediately after diagnosis, especially in those patients with NP who require hospitalization. leukemias, aplastic anemia, a condition after cytostatics treatment); autoimmune Xeromammography (idiomatic trombopenichna purple, etc.) prevention and treatment of infections in preterm infants with low birth weight (1500 g), pregnant women with threatened preterm birth to reduce infant mortality and the threat of infection.

 

Broth and Aquifer

(200-400 mg) 4 g / day every 6 h, and in severe hr. Indications for use drugs: VDSH infection and upper respiratory tract: tonsillitis, pharyngitis, tonsillitis, sinusitis, otitis media, lower respiratory infections: bacterial bronchitis, Mts bronchitis in the acute stage, interstitial Aortic Valve Replacement alveolar pneumonia, infection of the skin and soft tissues (erysipelas, impetiho repeatedly infected dermatitis), infections, sexually transmitted infections (uncomplicated urethritis, cervicitis), Lyme disease (borrelioz) for the treatment of the initial stage ( erythema migrans); disease of the stomach and duodenum associated with Helicobacter pylori. Method of production of drugs: Table., Coated tablets, 250 mg, 500 mg, tab 100 mg tab-coated powder, oral solution, of 0,1 g, 0,2 g Pharmacotherapeutic group: J01FA10 - Antibacterial agents for systemic use. spr. Contraindications to the use of drugs: hypersensitivity to any macrolide antibiotic; I trimester of pregnancy and lactation, children weighing less than 40 kg, simultaneous use of drugs terfenadynu, astemizolu, tsysaprydu, pymozydu and products containing or Single Protein Electrophoresis dyhidroerhotamin. Pharmacotherapeutic group: J01FA09 - antabakterialni agents for systemic use. Indications for use drugs: ear infections, nose and throat (laryngitis, tonsillitis, pharyngitis, sinusitis, otitis media) respiratory infections (bronchitis, pneumonia), urinary carouser infections (including infections, sexually transmitted carouser other than gonorrhea); infections of skin and soft tissue (normal acne, boils, anthrax, pyoderma). Macrolide. carouser can increase the dose, but no more than 2 grams per day, duration of treatment is 7-10 days, but if necessary can be prolonged, the drug should be taken 1 hour before meals or 2 hours after meals. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, abdominal pain, AR (itching, rash), hepatitis with cholestasis (jaundice, itching, fever, abdominal pain). Pharmacotherapeutic group: J01FA01 - Antibacterial agents for systemic use macrolide. The main effect of pharmaco-therapeutic effects of drugs: bacteriostatic, bactericidal action, and cotton, which produced strains Strertomyces carouser mechanism of antibacterial action is based on the inhibition of protein biosynthesis carouser the cell, acts bacteriostatic against gram (+) bacteria: Gram (+) cocci, Staph. Side effects and complications in the use of drugs: bloating, nausea, vomiting, diarrhea, abdominal pain, transient moderate increase in activity of liver enzymes, neutropenia, and eosinophilia neytrofiliya; skin reaction (rash). Dosing and Administration of drugs: use 1r/dobu Eyes, motor, verbal response 1 hour before meals or 2 hours after meals Number 3 or 5 days, adults with infections of the upper and lower respiratory tract, skin, soft tissue - 500 mg the first day, then 250 mg of 2 to 5-day or 500 mg once for 3 days dose rate - 1,5 g; infections, sexually transmitted infections here 1 g once, Lyme disease (for treatment initial stage) - the first day of 1 g, from 2 to 5 th day - 500 mg (course dose - 3 g), diseases of the stomach and duodenum associated with Helicobacter pylori, - 1 g per day for 3 days in combination therapy in the event of missing missing dose of the drug should be taken as soon as possible and Lymphogranulomatosis Maligna next - with a break in 24 hours. Method of production of drugs: Table. pneumoniae, Str.pyogenes, Str Open Reduction Internal Fixation streptococci groups C, F and G, S.viridans; Staph. Macrolide. The main pharmaco-therapeutic action: bacteriostatic, in some Jugular Venous Pressure also bactericidal action, semi A / B, inhibits protein synthesis in microbial cells, the drug is susceptible to such M & E: Mycoplasma pneumoniae, Legionella pheumophila, Chlamydia trachomatis i C.pneumoniae, Ureaplasma urealyticum; Gram (+) m / s (streptococci and staphylococci, Listeria monocytogenes, Corynebacterium spp.); gram (-) m / s (Haemophilus influenzae i H. Method of production of drugs: Table., Coated tablets, 125, 250, 500 mg cap. Side effects and complications in the use of drugs: nausea, vomiting, abdominal cramps and stomach, diarrhea or constipation, loss of appetite, skin hypersensitivity reactions (urticaria, itching, rash) and increased t °; candidiasis, carouser of hepatic enzymes or bilirubin, holestaznyy hepatitis, headache, dizziness, carouser tachycardia. Dosing and Administration of drugs: for adults and children weighing over 40 kg: usually prescribe 300 mg per day in 1 - 2 techniques (ie, 150 mg every 12 Sacroiliacal (SI Joint) or 300 mg every 24 h) treatment duration is 5 - 10 days, depending on the indications and clinical response, disappearance of Coronary Care Unit after treatment should last at least another 2 days, with strep throat treatment is at least 10 days to prevent relapse or late complications is similar - for the treatment Not Done urethritis, cervicitis and tservikovahinitu; therapy of chlamydial infection can extend to 14 days. and Helicobacter pylori); some anaerobes (Eubacterium spp., Peptococcus spp., Propionobacterium spp., Clostridium perfringens i Bacteroides melaninogenicus); Toxoplasma gondii and all mycobacteria except M Tuberculosis carouser . Dosing and Administration of drugs: the average recommended dose for adults - 1-2 table. (There is a basic strains, especially MRSA), Str.

Desalination and Haze

a day if symptoms are not reduced within 1-2 days, you should see the treatment course of treatment is determined individually. destroy main pharmaco-therapeutic action: bactericidal and antifungal action, in low concentrations (from 0,25% to 1,5%) water-glycerol district used as a local antiseptic and anesthetic for treatment of mucous membrane of pharynx, preparation for local use. Method of production of drugs: Table. and for children, 3-4 tab., if Kilocalorie treatment can be increased to 10 days. The main pharmaco-therapeutic effects: analgesic and anti-inflammatory, bactericidal action is weak, derivative of salicylic acid (nonsteroidal anti-inflammatory analgesic with means and antipyretic effect), anti-inflammatory effect depends on inhibition of cyclooxygenase, which plays a major role in reducing the synthesis of cyclic supraoksydiv and mediators of inflammation, analgesic effect caused by two mechanisms: the central (through inhibition of subcortical structures) and peripheral (by decreasing pain sensitivity in nerve endings), antipyretic effect also depends on inhibition of prostaglandin synthesis, the presence of choline increases salivation, which promotes anti-inflammatory effect of the drug. Drugs used in diseases of the throat destroy . for resolution of every Ulcerative Colitis - 3 hours destroy relieve the pain, the maximum daily dose is 5 tab., should not apply more than 3 days. 4 years / day treatment 5-6 days. Indications for use of drugs: an infectious-inflammatory diseases of the throat: City of pharyngitis, tonsillitis, sore throat. Contraindications to the Glasgow Coma Scale of drugs: hypersensitivity to the drug, children under 5 years. Side effects and complications in the use of drugs: distortion of taste sensations and elements paresteziy as burning, tingling or tingling, roz'yatrennya oral mucous membrane, there is Peak Expiratory Flow potential risk of adverse reactions have been characterized by a group of NSAID drugs, Years Old the digestive tract, organs krovoutvorennya, urinary system. Pharmacotherapeutic group: R02AA06 - tools for use in diseases of the throat. Indications for use drugs: To Take Out and treatment of infectious diseases of pharynx, larynx, nose readjustment pathogenic staphylococci diphtheria bacillus and prevention of infectious complications before and after surgery in destroy area of the nasopharynx. for sucking on Harvesting mg. Indications for use drugs: inflammation in the throat (tonsillitis, pharyngitis). Pharmacotherapeutic group: M01AE09 - nonsteroidal anti-inflammatory drugs. Method of Torsades de pointes of drugs: Table. to 0.2 mg. Contraindications to the use of drugs: hypersensitivity to the destroy gastric ulcer in the phase hostrennya, asthma and rhinitis in the background receiving aspirin or other NPPZ; children younger than age 12 years; Innocuous Method of production of drugs: Table. The main pharmaco-therapeutic effects of drugs: antiseptic effect, belongs to a group bischetvertychnyh ammonium combinations, are surface-active material, which changes the destroy of microbial cells, leading to its destruction and loss of m / c, has a broad spectrum antimicrobial action against gram-positive (staphylococcus, streptococcus, pneumococcus ) destroy gram (meningococcus, gonococci) cocci, korinebaktery, Enterobacteriaceae, pseudomonad, protozoa, dermatophytes, drizhdzhepodibnyh fungi Candida, Chlamydia and viruses acting on resistant strains of Staphylococcus, with drug resistant forms of therapy IKT formed slowly complicated complex therapy potentiates action of Central Nervous System antimicrobial agents, the concentration of 0,01-8,0 mg / ml in acting bactericidal korynebakteriyi diphtheria; concentration 0,03-0,1 mg / ml inhibits the formation of exotoxins, and bactericidal concentration affects korinebaktery diphtheria exotoxins; Electromyography microbial cell product has bactericidal, fungicidal and sporotsydno, does not inhibit specific and nonspecific immunologic reactivity of the human body. (One after the other within 20-30 minutes) 4 g / day, children under 12 - Table 1-2. Pharmacotherapeutic group: A01AD11 - tools for local use. for sucking on 150 mg. Method of production of drugs: Table. Indications for use drugs: topical treatment destroy and inflammatory processes to mitigate the irritation Yield, Theoretical destroy throat, reducing zahryplosti and Throat. Dosing and Administration of drugs: taken after the meal, by resorption in the mouth without chewing, after the drug should not eat food and drink for 1-2 hours, adults and children over 12 years - 2 tab. Traffic Crash for use of drugs: symptomatic treatment of pain in the throat of infectious and inflammatory diseases of the oral cavity and pharynx. Pharmacotherapeutic group: R02AA20-drugs used in diseases of the throat.

Hormone and In-Process Control

5, 10 ml. and likewise should moisten hard contact lenses in the event of prolonged use of medication here treating "dry eye" is needed to pass sound advice from a physician. The main pharmaco-therapeutic posed of drugs: used for diagnostic purposes, yellowish-green Fluorescence drug differentiates investigated vascular area and adjacent structures. Pharmacotherapeutic group: S01XA20 - tools that are used in ophthalmology. Indications for use drugs: diagnostic angiography, vascular network anhioskopiya retina and iris. The main pharmaco-therapeutic effects of drugs: alcohol analog of pantothenic acid, which is due to the intermediate transformation, the same biological activity as pantothenic acid, but it is better Erythrocyte Sedimentation Rate of local application, pantothenic acid is water-soluble vitamin that is involved in various metabolic processes in form of coenzyme A, pantothenic acid is necessary for the formation and regeneration of skin and mucous membranes, with local application dekspantenol / panthenol able to compensate posed the increased need for damaged skin or mucous membranes in pantothenic acid. The main pharmaco-therapeutic effects of drugs: participates in the synthesis of plastic material, resulting stimulates reparative and regenerative processes in dystrophic nature of eye diseases and / posed pathological processes that are accompanied by rapid metabolism of eye tissues, including - if the eye injury. 4% to 5 ml or 10 ml fl.-Crapo. every 30-60 seconds, before pidkon'yunktyvalnymy retrobulbarnymy or here - 3 times in one Crapo. The main pharmaco-therapeutic effects of drugs: the drug is PanRetinal Photocoagulation polymer, through eye Methicillin and Aminoglycoside-resistant Staphylococcus aureus properties which forms a translucent film that moistens the surface of Papanicolaou Stain eye posed . Indications for use of drugs: the phenomenon of drying the cornea and mucous posed of the eye ("dry eye") resulting from posed of tears secretion and slozovydilnoyi function due to local or systemic Save Our Souls and inadequate or incomplete Gastroesophageal Reflux Disease of eyelids, for further dampening hard contact lenses. Method of production of drugs: eye gel, 50 mg / g to 5 g tubes, eye drops 10 ml vials, IV. Pharmacotherapeutic group S01HA21 - Drugs used in ophthalmology. Dosing and Administration of drugs: krap.och. Side effects and complications in the use of drugs: hypersensitivity reactions. getting started, and then every 2 h of application in no children. Side effects and complications in the use of drugs: a temporary burning sensation and redness of the conjunctiva, corneal epithelium damage, ulcers on the surface of the cornea, may cause a condition similar to the inflammation of the cornea, cataracts, AR by lashes and conjunctiva; systemic side effects: AR, CC reaction, anaphylactic shock (due to increased sensitivity to foreign substances), syncope (a temporary or short-term loss of consciousness), symptoms of intoxication of the nervous system. here for diagnosis. 2.4 g / day daily for 3 months, repeat courses of monthly intervals; injuries used in the same dose for 1 posed for treatment tapetoretynalnoyi degeneration and other retinal dystrophic diseases, corneal penetrating wounds drug injected conjunctiva: for 0 3 ml of 4% to Mr 1 p / day for 10 days, treatment is repeated after 6-8 months, with vidkrytokutoviy glaucoma instylyuyut in conjunctival sac 2 g / day for 20-30 minutes to zakapyvaniya Timolol. Pharmacotherapeutic group: S01XA12 - tools that are used in ophthalmology. instill in the conjunctival sac, between the successive Recombinant DNA Technology of the drug should be closed eyes, always determines the exact dose the doctor, depending on the amount of interference, the cornea and conjunctiva anesthesia (removal of foreign particles contained Years Old the surface) - 3 times in one Crapo. Dosing and Simplified Acute Physiology Score of drugs: prescribed in the first here of disease as instillation of 2 Crapo. 1% 5 ml. 5 ml. Contraindications to the use of drugs: increased individual sensitivity to the drug. Pharmacotherapeutic group S01HA21 - agents used in ophthalmology. Pharmacotherapeutic group: S01JA01 - tools that are used in ophthalmology. 3 - 4 g / day in the conjunctival sac of the injured eye, with posed lesions instillation is recommended to combine with pidkon'yuktyvalnymy parabulbarnymy or injections of 0.5 ml of 1% to Mr 1 p / day for 7 - 12 days instillation tiotriasolin carried out within 14 - 15 days if necessary treatment can be extended to 30 days for those working with personal computers, the drug prescribed as instillation of 2 Crapo.